Oncological Sciences

Medicine & Life Sciences

1. Neoplasms 100%
2. T-Lymphocytes 50%
3. Proteins 48%
4. Phosphotransferases 44%
5. Genes 43%
6. DNA Damage 40%
7. Mutation 39%
8. Melanoma 32%
9. Apoptosis 32%
10. Chromatin 31%
11. Immunity 28%
12. Growth 28%
13. Phosphorylation 27%
14. Ubiquitin 27%
15. Cyclin-Dependent Kinases 27%
16. Histones 27%
17. Therapeutics 27%
18. Epigenomics 27%
19. Ubiquitin-Protein Ligases 26%
20. Ubiquitination 26%
21. Oncogenes 26%
22. Immunotherapy 24%
23. Coronavirus 24%
24. SARS Virus 22%
25. In Vitro Techniques 21%
26. Multiple Myeloma 21%
27. Methylation 20%
28. Phenotype 20%
29. Cullin Proteins 20%
30. Schizosaccharomyces 20%
31. Breast Neoplasms 19%
32. Dendritic Cells 19%
33. DNA 19%
34. Cell Cycle 18%
35. Proteolysis 18%
36. Cell Line 17%
37. Prostatic Neoplasms 17%
38. Protein-Arginine N-Methyltransferases 17%
39. Carcinogenesis 16%
40. Gene Expression 16%
41. Hepatocellular Carcinoma 16%
42. Ligands 16%
43. Biomarkers 15%
44. Induced Pluripotent Stem Cells 15%
45. Cell Cycle Checkpoints 15%
46. Lysine 15%
47. RNA Polymerase II 15%
48. Severe Acute Respiratory Syndrome 15%
49. Neoplasm Metastasis 14%
50. Cell Death 14%
51. Inflammation 14%
52. Transcription Factors 14%
53. Transcriptional Activation 14%
54. ON 01910 14%
55. Cytokines 14%
56. Macrophages 14%
57. Genome 14%
58. Cell Proliferation 13%
59. Pharmaceutical Preparations 13%
60. B-Lymphocytes 13%
61. Myeloid Cells 13%
62. Survival 13%
63. Catenins 13%
64. Antigens 13%
65. MicroRNAs 12%
66. DNA Repair 12%
67. Cell Survival 12%
68. Down-Regulation 11%
69. Fibroblasts 11%
70. hematopoietic progenitor kinase 1 11%
71. Lymphangiogenesis 11%
72. Natural Killer Cells 11%
73. Clone Cells 11%
74. Drosophila 11%
75. Methyltransferases 10%
76. Polycomb Repressive Complex 2 10%
77. Signal Transduction 10%
78. Viruses 10%
79. Stem Cells 10%
80. Leukemia 10%
81. Cellular Senescence 10%
82. Cytotoxic T-Lymphocytes 10%
83. Interferons 10%
84. Monocytes 10%
85. Mitosis 10%
86. Vaccines 10%
87. Phosphatidylinositol 3-Kinases 10%
88. Interferon Type I 10%
89. RNA 10%
90. Enhancer of Zeste Homolog 2 Protein 10%
91. Ligases 10%
92. p53 Genes 9%
93. Tumor Microenvironment 9%
94. Messenger RNA 9%
95. Antiviral Agents 9%
96. Mitogen-Activated Protein Kinase Kinases 9%
97. Lymphatic Vessels 9%
98. Acute Myeloid Leukemia 9%
99. Maintenance 9%
100. Proteasome Endopeptidase Complex 9%